TCTMD’s Top 10 Most Popular Stories for October 2020
Most of the top stories stemmed from TCT Connect, but a PCI vs surgery analysis and the COVID-19 Daily Dispatch took top spots.
TCTMD’s coverage of diverse coronary and structural late-breaking clinical trials from the virtual TCT Connect meeting dominated our top 10 list this month, with MitraBridge, SCOPE 2, and SOLVE-TAVI making the top five. But once again, our daily brief summing up the breaking COVID-19 research and policy news proved popular—bookmark it!—while a meta-analysis from JAMA Internal Medicine, addressing overall and cause-specific mortality in trials comparing PCI and CABG surgery, nabbed the top spot.
All-cause mortality is the most “unbiased” primary endpoint, the authors argue. David Kandzari calls this an oversimplification
We’re curating a list of COVID-19 research and other useful content, and updating it every, single weekday.
Researchers were “surprised” that 25% of patients rallied enough to leave the transplant list. Figuring out who and how remains.
Having failed noninferiority tests against two leading devices, Acurate neo’s niche is now in question, experts said.
Stroke rates for the balloon-expandable device far exceeded those of the Evolut R; conscious sedation was also a clear winner.
Lipid-rich lesions pose a higher risk, but not everybody is sold yet that stenting these non-flow-limiting lesions is the way to go.
“Jaw-dropping” and “spectacular” were some of the adjectives describing the calcium-cracking in early, nonrandomized results.
More bleeding, but no ischemic benefit, was seen with ticagrelor versus clopidogrel in this observational, real-world study.
Attention is turning to symptom relief and how best to align treatment with the patient’s goals and preferences.
Aspirin alone after 1 or 3 months was noninferior to historical controls, with significantly less major bleeding.
* * *
For more takeaways from TCT Connect, check out a special edition of the Heart Sounds podcast, where some of the meeting’s “social media ambassadors” weigh in on what they learned. All of TCTMD’s coverage from TCT Connect can be found on our conference page. Our COVID-19 reporting—news, videos, and podcasts—can be found on our COVID-19 Hub.